Abstract
Dementia in Parkinson's disease has previously been attributed to the presence in the cerebral cortex of Alzheimer-type neuropathological abnormalities. New evidence suggests, however, that dementia in this disease usually occurs in the absence of substantial Alzheimer-type changes in the cortex and may be related to abnormalities in the cortical cholinergic system. Thus, in Parkinsonian patients with dementia there were extensive reductions of choline acetyltransferase and less extensive reductions of acetylcholinesterase in all four cortical lobes. Choline acetyltransferase reductions in temporal neocortex correlated with the degree of mental impairment assessed by a test of memory and information but not with the extent of plaque or tangle formation. In Parkinson's but not Alzheimer's disease the decrease in neocortical (particularly temporal) choline acetyltransferase correlated with the number of neurons in the nucleus of Meynert suggesting that primary degeneration of these cholinergic neurons may be related, directly or indirectly, to declining cognitive function in Parkinson's disease.
Full text
PDF![413](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb88/1028327/0c5fe6595463/jnnpsyc00109-0021.png)
![414](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb88/1028327/348c216da577/jnnpsyc00109-0022.png)
![415](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb88/1028327/c276227375fa/jnnpsyc00109-0023.png)
![416](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb88/1028327/0f7e789b8610/jnnpsyc00109-0024.png)
![417](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb88/1028327/34445ccfb751/jnnpsyc00109-0025.png)
![418](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb88/1028327/238bee5c1e6f/jnnpsyc00109-0026.png)
![419](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb88/1028327/cc0d229f45a3/jnnpsyc00109-0027.png)
![420](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb88/1028327/430d9683867d/jnnpsyc00109-0028.png)
![421](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb88/1028327/d3ce4c91823d/jnnpsyc00109-0029.png)
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Atack J. R., Perry E. K., Bonham J. R., Perry R. H., Tomlinson B. E., Blessed G., Fairbairn A. Molecular forms of acetylcholinesterase in senile dementia of Alzheimer type: selective loss of the intermediate (10S) form. Neurosci Lett. 1983 Sep 30;40(2):199–204. doi: 10.1016/0304-3940(83)90302-6. [DOI] [PubMed] [Google Scholar]
- Blessed G., Tomlinson B. E., Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968 Jul;114(512):797–811. doi: 10.1192/bjp.114.512.797. [DOI] [PubMed] [Google Scholar]
- Candy J. M., Perry R. H., Perry E. K., Irving D., Blessed G., Fairbairn A. F., Tomlinson B. E. Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases. J Neurol Sci. 1983 May;59(2):277–289. doi: 10.1016/0022-510x(83)90045-x. [DOI] [PubMed] [Google Scholar]
- Cross A. J., Crow T. J., Johnson J. A., Perry E. K., Perry R. H., Blessed G., Tomlinson B. E. Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer-type. J Neurol Sci. 1984 May;64(2):109–117. doi: 10.1016/0022-510x(84)90029-7. [DOI] [PubMed] [Google Scholar]
- Drachman D. A., Leavitt J. Human memory and the cholinergic system. A relationship to aging? Arch Neurol. 1974 Feb;30(2):113–121. doi: 10.1001/archneur.1974.00490320001001. [DOI] [PubMed] [Google Scholar]
- ENGLAND A. C., SCHWAB R. S., PETERSON E. The electroencephalogram in Parkinson's syndrome. Electroencephalogr Clin Neurophysiol. 1959 Nov;11:723–731. doi: 10.1016/0013-4694(59)90111-7. [DOI] [PubMed] [Google Scholar]
- Gordon E. B., Sim M. The E.E.G. in presenile dementia. J Neurol Neurosurg Psychiatry. 1967 Jun;30(3):285–291. doi: 10.1136/jnnp.30.3.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hakim A. M., Mathieson G. Dementia in Parkinson disease: a neuropathologic study. Neurology. 1979 Sep;29(9 Pt 1):1209–1214. doi: 10.1212/wnl.29.9_part_1.1209. [DOI] [PubMed] [Google Scholar]
- LETEMENDIA F., PAMPIGLIONE G. Clinical and electroencephalographic observations in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1958 Aug;21(3):167–172. doi: 10.1136/jnnp.21.3.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lees A. J., Smith E. Cognitive deficits in the early stages of Parkinson's disease. Brain. 1983 Jun;106(Pt 2):257–270. doi: 10.1093/brain/106.2.257. [DOI] [PubMed] [Google Scholar]
- Lloyd K. G., Möhler H., Heitz P., Bartholini G. Distribution of choline acetyltransferase and glutamate decarboxylase within the substantia nigra and in other brain regions from control and Parkinsonian patients. J Neurochem. 1975 Dec;25(6):789–795. doi: 10.1111/j.1471-4159.1975.tb04409.x. [DOI] [PubMed] [Google Scholar]
- Lo Conte G., Casamenti F., Bigl V., Milaneschi E., Pepeu G. Effect of magnocellular forebrain nuclei lesions on acetylcholine output from the cerebral cortex, electrocorticogram and behaviour. Arch Ital Biol. 1982 May;120(1-3):176–188. [PubMed] [Google Scholar]
- Mesulam M. M., Mufson E. J., Levey A. I., Wainer B. H. Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J Comp Neurol. 1983 Feb 20;214(2):170–197. doi: 10.1002/cne.902140206. [DOI] [PubMed] [Google Scholar]
- Perry E. K., Perry R. H., Candy J. M., Fairbairn A. F., Blessed G., Dick D. J., Tomlinson B. E. Cortical serotonin-S2 receptor binding abnormalities in patients with Alzheimer's disease: comparisons with Parkinson's disease. Neurosci Lett. 1984 Oct 26;51(3):353–357. doi: 10.1016/0304-3940(84)90402-6. [DOI] [PubMed] [Google Scholar]
- Perry E. K., Tomlinson B. E., Blessed G., Bergmann K., Gibson P. H., Perry R. H. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J. 1978 Nov 25;2(6150):1457–1459. doi: 10.1136/bmj.2.6150.1457. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Perry R. H., Candy J. M., Perry E. K., Irving D., Blessed G., Fairbairn A. F., Tomlinson B. E. Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease. Neurosci Lett. 1982 Dec 13;33(3):311–315. doi: 10.1016/0304-3940(82)90391-3. [DOI] [PubMed] [Google Scholar]
- Perry R. H., Candy J. M., Perry E. K., Thompson J., Oakley A. E. The substantia innominata and adjacent regions in the human brain: histochemical and biochemical observations. J Anat. 1984 Jun;138(Pt 4):713–732. [PMC free article] [PubMed] [Google Scholar]
- Perry R. H., Tomlinson B. E., Candy J. M., Blessed G., Foster J. F., Bloxham C. A., Perry E. R. Cortical cholinergic deficit in mentally impaired Parkinsonian patients. Lancet. 1983 Oct 1;2(8353):789–790. doi: 10.1016/s0140-6736(83)92317-6. [DOI] [PubMed] [Google Scholar]
- Reisine T. D., Fields J. Z., Yamamura H. I. Neurotransmitter receptor alterations in Parkinson's disease. Life Sci. 1977 Aug 1;21(3):335–343. doi: 10.1016/0024-3205(77)90514-8. [DOI] [PubMed] [Google Scholar]
- Ruberg M., Ploska A., Javoy-Agid F., Agid Y. Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia. Brain Res. 1982 Jan 28;232(1):129–139. doi: 10.1016/0006-8993(82)90615-1. [DOI] [PubMed] [Google Scholar]
- Tomlinson B. E., Blessed G., Roth M. Observations on the brains of demented old people. J Neurol Sci. 1970 Sep;11(3):205–242. doi: 10.1016/0022-510x(70)90063-8. [DOI] [PubMed] [Google Scholar]
- Whitehouse P. J., Hedreen J. C., White C. L., 3rd, Price D. L. Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol. 1983 Mar;13(3):243–248. doi: 10.1002/ana.410130304. [DOI] [PubMed] [Google Scholar]
- Whitehouse P. J., Price D. L., Struble R. G., Clark A. W., Coyle J. T., Delon M. R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science. 1982 Mar 5;215(4537):1237–1239. doi: 10.1126/science.7058341. [DOI] [PubMed] [Google Scholar]
- Wilcock G. K., Esiri M. M., Bowen D. M., Smith C. C. Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J Neurol Sci. 1982 Dec;57(2-3):407–417. doi: 10.1016/0022-510x(82)90045-4. [DOI] [PubMed] [Google Scholar]